Trevi Therapeutics, Inc. Profile Avatar - Palmy Investing

Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation…

Biotechnology
US, New Haven [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Trevi Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Trevi Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Trevi Therapeutics, Inc..

End of TRVI's Analysis
CIK: 1563880 CUSIP: 89532M101 ISIN: US89532M1018 LEI: - UEI: -
Secondary Listings
TRVI has no secondary listings inside our databases.